Recruiting Deep Vein Thrombosis Studies in Aurora
A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE
This is a Phase 3, multicenter, open-label, blinded endpoint study to evaluate the effect of abelacimab relative to dalteparin on venous thromboembolism (VTE) recurrence and bleeding in patients with ...
Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies
The goal of the CRETE Studies is to investigate the newly identified age-dependent heterogeneity in the efficacy of enoxaparin in reducing the risk of central venous catheter-associated deep venous th...
About Deep Vein Thrombosis Clinical Trials in Aurora
Deep vein thrombosis (DVT) occurs when a blood clot forms in a deep vein, usually in the legs. It can be dangerous if the clot breaks loose and travels to the lungs (pulmonary embolism). Treatment includes blood thinners and sometimes clot-removal procedures.
There are currently 2 deep vein thrombosis clinical trials recruiting participants in Aurora, ILLINOIS. These studies are seeking a combined 1,278 participants. Research is being sponsored by Anthos Therapeutics, Inc., Yale University. Clinical trial participation is free and participants receive study-related medical care at no cost.
Deep Vein Thrombosis Clinical Trials in Aurora — FAQ
Are there deep vein thrombosis clinical trials in Aurora?
Yes, there are 2 deep vein thrombosis clinical trials currently recruiting in Aurora, ILLINOIS. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Aurora?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Aurora research site will contact you about next steps.
Are clinical trials in Aurora free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Aurora studies also compensate for your time and travel.
What deep vein thrombosis treatments are being tested?
The 2 active trials in Aurora are testing new therapies including novel drugs, biologics, and treatment approaches for deep vein thrombosis.
Data updated March 2, 2026 from ClinicalTrials.gov